Cargando…

SLC6 transporter oligomerization

Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix‐spanning proteins that operate using the transmembrane sodium gradient for transport. These tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayaraman, Kumaresan, Das, Anand K., Luethi, Dino, Szöllősi, Dániel, Schütz, Gerhard J., Reith, Maarten E. A., Sitte, Harald H., Stockner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247324/
https://www.ncbi.nlm.nih.gov/pubmed/32767560
http://dx.doi.org/10.1111/jnc.15145
_version_ 1783716498886361088
author Jayaraman, Kumaresan
Das, Anand K.
Luethi, Dino
Szöllősi, Dániel
Schütz, Gerhard J.
Reith, Maarten E. A.
Sitte, Harald H.
Stockner, Thomas
author_facet Jayaraman, Kumaresan
Das, Anand K.
Luethi, Dino
Szöllősi, Dániel
Schütz, Gerhard J.
Reith, Maarten E. A.
Sitte, Harald H.
Stockner, Thomas
author_sort Jayaraman, Kumaresan
collection PubMed
description Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix‐spanning proteins that operate using the transmembrane sodium gradient for transport. These transporters assume various quaternary arrangements ranging from monomers to complex stoichiometries with multiple subunits. Dopamine and serotonin transporter oligomerization has been implicated in trafficking of newly formed proteins from the endoplasmic reticulum to the plasma membrane with a pre‐fixed assembly. Once at the plasma membrane, oligomers are kept fixed in their quaternary assembly by interaction with phosphoinositides. While it remains unclear how oligomer formation precisely affects physiological transporter function, it has been shown that oligomerization supports the activity of release‐type psychostimulants. Most recently, single molecule microscopy experiments unveiled that the stoichiometry differs between individual members of the SLC6 family. The present overview summarizes our understanding of the influence of plasma membrane constituents on transporter oligomerization, describes the known interfaces between protomers and discusses open questions. [Image: see text]
format Online
Article
Text
id pubmed-8247324
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82473242021-07-02 SLC6 transporter oligomerization Jayaraman, Kumaresan Das, Anand K. Luethi, Dino Szöllősi, Dániel Schütz, Gerhard J. Reith, Maarten E. A. Sitte, Harald H. Stockner, Thomas J Neurochem Review Transporters of the solute carrier 6 (SLC6) family mediate the reuptake of neurotransmitters such as dopamine, norepinephrine, serotonin, GABA, and glycine. SLC6 family members are 12 transmembrane helix‐spanning proteins that operate using the transmembrane sodium gradient for transport. These transporters assume various quaternary arrangements ranging from monomers to complex stoichiometries with multiple subunits. Dopamine and serotonin transporter oligomerization has been implicated in trafficking of newly formed proteins from the endoplasmic reticulum to the plasma membrane with a pre‐fixed assembly. Once at the plasma membrane, oligomers are kept fixed in their quaternary assembly by interaction with phosphoinositides. While it remains unclear how oligomer formation precisely affects physiological transporter function, it has been shown that oligomerization supports the activity of release‐type psychostimulants. Most recently, single molecule microscopy experiments unveiled that the stoichiometry differs between individual members of the SLC6 family. The present overview summarizes our understanding of the influence of plasma membrane constituents on transporter oligomerization, describes the known interfaces between protomers and discusses open questions. [Image: see text] John Wiley and Sons Inc. 2020-08-28 2021-05 /pmc/articles/PMC8247324/ /pubmed/32767560 http://dx.doi.org/10.1111/jnc.15145 Text en © 2020 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Jayaraman, Kumaresan
Das, Anand K.
Luethi, Dino
Szöllősi, Dániel
Schütz, Gerhard J.
Reith, Maarten E. A.
Sitte, Harald H.
Stockner, Thomas
SLC6 transporter oligomerization
title SLC6 transporter oligomerization
title_full SLC6 transporter oligomerization
title_fullStr SLC6 transporter oligomerization
title_full_unstemmed SLC6 transporter oligomerization
title_short SLC6 transporter oligomerization
title_sort slc6 transporter oligomerization
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247324/
https://www.ncbi.nlm.nih.gov/pubmed/32767560
http://dx.doi.org/10.1111/jnc.15145
work_keys_str_mv AT jayaramankumaresan slc6transporteroligomerization
AT dasanandk slc6transporteroligomerization
AT luethidino slc6transporteroligomerization
AT szollosidaniel slc6transporteroligomerization
AT schutzgerhardj slc6transporteroligomerization
AT reithmaartenea slc6transporteroligomerization
AT sitteharaldh slc6transporteroligomerization
AT stocknerthomas slc6transporteroligomerization